Evonetix closes $24M financing
Evonetix Ltd, a synthetic biology company bringing semiconductor technology to DNA synthesis, has completed a…
Evonetix Ltd, a synthetic biology company bringing semiconductor technology to DNA synthesis, has completed a…
AbbVie has announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved…
By Oxford BioDynamics Cancer care is in urgent need of effective tests to determine the…
BiVictriX Therapeutics plc has announced positive in vivo data from a toxicity evaluation study with…
Ubiquigent Limited, a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new…
Medical research charity LifeArc, the Motor Neurone Disease Association (MND Association) and the My Name’5…
One of the biggest global challenges facing healthcare systems is bacteria and viruses becoming resistant…
pHion Therapeutics is a U.K.-based vaccine development company. It is developing a pipeline of therapeutic…
Cambridge U.K. biotech company SolasCure, which is developing a wound cleaning technology, has published its…
Multus Biotechnology Limited, a U.K.-based start-up creating ingredients for the affordable scale-up of cellular agriculture,…
TTP plc, a technology and product development company, has announced the launch of Cellular Origins. …
A new Memorandum of Understanding (MoU) to facilitate collaboration in the field of pandemic preparedness…